FDA Peptide Reclassification 2026: What It Means for Providers This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction